Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4518 (MIR4518) is a human gene encoding a small (~22 nucleotide) non-coding RNA that functions as part of the microRNA (miRNA) family. MiRNAs are transcribed from specific genes as a primary transcript, processed into a hairpin precursor, exported from the nucleus, and further processed by Dicer into a mature miRNA molecule. The mature MIR4518, like other miRNAs, is incorporated into the RNA-induced silencing complex (RISC), where it binds target messenger RNAs through sequence complementarity, leading to either translation inhibition or mRNA degradation. MicroRNAs control a broad spectrum of biological processes post-transcriptionally and are involved in the fine-tuning of gene expression. While microRNAs as a class are crucial in diseases such as cancer, neurodegenerative disorders, and cardiovascular disease, MIR4518 itself does not currently have well-defined functions or disease roles in the literature[2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4518 (MIR4518).